Creative Medical Tech
(NASDAQ:CELZ)
$4.22
-0.1201[-2.77%]
At close: May 6
$4.22
0[0.00%]
After Hours: 5:47PM EDT
Consensus Rating1
Buy
Highest Price Target1
$10.00
Lowest Price Target1
$10.00
Consensus Price Target1
$10.00

Creative Medical Tech Stock (NASDAQ:CELZ), Analyst Ratings, Price Targets, Predictions

Creative Medical Technology Holdings Inc has a consensus price target of $10, established from looking at the 1 latest analyst ratings. The last 1 analyst ratings were released from Roth Capital on February 25, 2022. With an average price target of $10 between Roth Capital, there's an implied 136.97% upside for Creative Medical Technology Holdings Inc from these 1 analyst ratings.

Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Roth Capital

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Creative Medical Tech

Buy NowGet Alert
02/25/2022Buy Now136.97%Roth Capital
Jonathan Aschoff
→ $100Initiates → BuyGet Alert

FAQ

Q

What is the target price for Creative Medical Tech (CELZ)?

A

The latest price target for Creative Medical Tech (NASDAQ: CELZ) was reported by Roth Capital on February 25, 2022. The analyst firm set a price target for $10.00 expecting CELZ to rise to within 12 months (a possible 136.97% upside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Creative Medical Tech (CELZ)?

A

The latest analyst rating for Creative Medical Tech (NASDAQ: CELZ) was provided by Roth Capital, and Creative Medical Tech initiated their buy rating.

Q

When was the last upgrade for Creative Medical Tech (CELZ)?

A

There is no last upgrade for Creative Medical Tech.

Q

When was the last downgrade for Creative Medical Tech (CELZ)?

A

There is no last downgrade for Creative Medical Tech.

Q

When is the next analyst rating going to be posted or updated for Creative Medical Tech (CELZ)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Creative Medical Tech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Creative Medical Tech was filed on February 25, 2022 so you should expect the next rating to be made available sometime around February 25, 2023.

Q

Is the Analyst Rating Creative Medical Tech (CELZ) correct?

A

While ratings are subjective and will change, the latest Creative Medical Tech (CELZ) rating was a initiated with a price target of $0.00 to $10.00. The current price Creative Medical Tech (CELZ) is trading at is $4.22, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch